Results 141 to 150 of about 19,505 (226)

Retraction: Shaoyao-Gancao Decoction alleviated hyperandrogenism in a letrozole-induced rat model of polycystic ovary syndrome by inhibition of NF-κB activation. [PDF]

Biosci Rep
Liu JJ, Hou RG, Shao YY, Chang ZP, Cheng Y, Wang XC, Zhang JP, Feng XJ, Guo YT.   +8 more
europepmc   +1 more source

Uncovering the Metabolic Origins of Polycystic Ovary Syndrome. [PDF]

Cureus
Iyer PJ, Reza H, Chitteti N, Singh A, Goyal R, Saiyad SS, Stephen Raj AER, Singla N, Vats B, Kamaladasan D, Chahal PS, Das A, Reddy P, Lakhani A.   +13 more
europepmc   +1 more source

Editorial: Sex steroid metabolism and obesity: insights from animal studies. [PDF]

Front Endocrinol (Lausanne)
den Hartigh LJ, Varghese M.
europepmc   +1 more source

Exploring emerging concepts in the pathophysiology of PCOS: microbiome dysbiosis and immunological dysregulation. [PDF]

Reprod Fertil
Kumar P, O'Reilly MW, McGowan K, Harrity C.   +3 more
europepmc   +1 more source

Ovarian Hyperandrogenism [PDF]

, 2020
openaire   +1 more source

Polycystic Ovary Syndrome Is Associated with Fatty Pancreas Disorder: A Case-Control Study in Non-Diabetic Women. [PDF]

J Clin Med
Severoglu H, Ateş F, Durukan H.
europepmc   +1 more source

Prevalence of polycystic ovary syndrome among adolescents depending on the adopted diagnostic criteria. [PDF]

Front Endocrinol (Lausanne)
Jakubowska-Kowal K, Skrzyńska K, Kowalczyk K, Gawlik-Starzyk A.   +3 more
europepmc   +1 more source

Adrenal AKR1C3-mediated androgen activation contributes to hyperandrogenism in prepubertal ovariectomized rats. [PDF]

Transl Pediatr
Gao G, Wang J, Zhan B, Li B, Shao Y, Han X, He J, Sun W, Yu J, Dong W.   +9 more
europepmc   +1 more source